Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 6/2019

17.09.2018 | Original Article

Establishing an integrative oncology service in the Australian healthcare setting—the Chris O’Brien Lifehouse Hospital experience

verfasst von: Suzanne J. Grant, Michael Marthick, Judith Lacey

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Comprehensive cancer centres are on the rise as patients seek a more holistic approach to maintaining their wellbeing when living with a cancer diagnosis. Many cancer centres worldwide now incorporate a selection of evidence-based complementary therapies and qualified therapists into their offerings. The Chris O’Brien Lifehouse, a comprehensive cancer centre in Sydney, Australia, provides integrative oncology services including acupuncture, massage, reflexology, dietetics and exercise physiology for individual patients, along with group programmes, and an integrative and supportive care medical specialist. The purpose of this paper is to reflect on one model of integrative oncology service and approach to integration and team and service development.
Literatur
1.
Smith CA, Hunter J, Ussher JM, Delaney GP, Grant S, Templeman K, Parton C, Kellett A (2017) Integrative oncology in Australia 2016: mapping service provision and exploring unmet needs. In. Penrith, N.S.W.: Western Sydney University
2.
Yun H, Sun L, Mao JJ (2017) Growth of integrative medicine at leading cancer centers between 2009 and 2016: a systematic analysis of NCI-designated comprehensive cancer center websites. J Natl Cancer Inst Monogr, 2017(52)
3.
Oh B, Butow P, Mullan B, Beale P, Pavlakis N, Rosenthal D, Clarke S (2010) The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia-Pac J Clin Oncol 6(4):342–349CrossRefPubMed
4.
Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187–203CrossRefPubMed
5.
Eisenberg DM, Kaptchuk TJ, Post DE, Hrbek AL, O’Connor BB, Osypiuk K, Wayne PM, Buring JE, Levy DB (2016) Establishing an integrative medicine program within an academic health center: essential considerations. Acad Med 91:1223–1230CrossRefPubMedPubMedCentral
6.
Robotin MC, Penman AG (2006) Integrating complementary therapies into mainstream cancer care: which way forward? Med J Aust 185(7):377PubMed
7.
Deng G, Cassileth BR (2005) Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin 55(2):109–116CrossRefPubMed
8.
9.
Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM: Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA: A Cancer Journal for Clinicians 2017
10.
Bell R (2010) A review of complementary and alternative medicine practices among cancer survivors. Clin J Oncol Nurs 14(3):365–370CrossRefPubMed
11.
King T, Grant S, Taylor S, Houteas K, Barnett C, White K (2015) A CAM do approach: the attitudes, use and disclosure of the use of complementary and alternative medicine (CAM) in those with myeloma. Clin Lymphoma Myeloma Leuk 15:e317–e318CrossRef
12.
Amichai T, Grossman M, Richard M (2012) Lung cancer patients’ beliefs about complementary and alternative medicine in the promotion of their wellness. Eur J Oncol Nurs 16(5):520–527CrossRefPubMed
13.
Rademakers J, Delnoij D, de Boer D (2011) Structure, process or outcome: which contributes most to patients’ overall assessment of healthcare quality? BMJ quality & safety:bmjqs. 2010.042358
14.
Deng G ( 2008) Integrative cancer care in a US academic cancer centre: the memorial Sloan-Kettering experience. Current oncology (Toronto, Ont), Suppl 2:s108
15.
Mittring N, Perard M, Witt CM (2013) Corporate culture assessments in integrative oncology: a qualitative case study of two integrative oncology centers. Evid Based Complement Alternat Med 2013:8CrossRef
16.
Boon HS, Kachan N (2008) Integrative medicine: a tale of two clinics. BMC Complement Altern Med 8(1):1CrossRef
17.
Pérard M, Mittring N, Schweiger D, Kummer C, Witt CM (2015) MERGING conventional and complementary medicine in a clinic department–a theoretical model and practical recommendations. BMC Complement Altern Med 15(1):1CrossRef
18.
Grant SJ, Hunter J, Bensoussan A, Delaney GP (2017) Guidance for establishing an integrative oncology service in the Australian healthcare setting-a discussion paper. Support Care Cancer
19.
Buffart LM, van Uffelen JG, Riphagen BJ II, van Mechelen W, Brown WJ, Chinapaw MJ (2012) Physical and psychosocial benefits of yoga in cancer patients and survivors, a systematic review and meta-analysis of randomized controlled trials. BMC Cancer 12:559CrossRefPubMedPubMedCentral
20.
Phillips SM, Alfano CM, Perna FM, Glasgow RE (2014) Accelerating translation of physical activity and cancer survivorship research into practice: recommendations for a more integrated and collaborative approach. Cancer Epidemiol Prev Biomark 23:687–699CrossRef
21.
Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, Pietanza MC, Cassileth BR (2013) Complementary therapies and integrative medicine in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e420S–e436SCrossRefPubMed
22.
Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):85PubMed
23.
Cassileth BR, Deng GE, Gomez JE, Johnstone PAS, Kumar N, Vickers AJ (2007) Complementary therapies and integrative oncology in lung cancer*: Accp evidence-based clinical practice guidelines (2nd edition). Chest 132(3_suppl):340S–354SCrossRefPubMed
24.
Filshie J, Hester J (2006) Guidelines for providing acupuncture treatment for cancer patients–a peer-reviewed sample policy document. Acupunct Med 24(4):172–182CrossRefPubMed
25.
Kerridge IH, McPhee JR (2004) Ethical and legal issues at the interface of complementary and conventional medicine. Med J Aust 181(3):164PubMed
26.
Kligler B, Homel P, Harrison LB, Levenson HD, Kenney JB, Merrell W (2011) Cost savings in inpatient oncology through an integrative medicine approach. Am J Manag Care 17(12):779–784PubMed
27.
Johnson JR, Crespin DJ, Griffin KH, Finch MD, Dusek JA (2014) Effects of integrative medicine on pain and anxiety among oncology inpatients. J Natl Cancer Inst Monogr 50(330):e337
28.
Robotin M, Holliday C, Bensoussan A (2012) Defining research priorities in complementary medicine in oncology. Complement Ther Med 20(5):345–352CrossRefPubMed
29.
Sagar SM (2008) How do we evaluate outcome in an integrative oncology program? Curr Oncol (Toronto, Ont) 15(Suppl 2):s78–s82
30.
Frenkel M, Cohen L (2008) Incorporating complementary and integrative medicine in a comprehensive cancer center. Hematol Oncol Clin North Am 22(4):727–736CrossRefPubMed
31.
Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM (2015) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557–565CrossRefPubMedPubMedCentral
32.
Hunter J, Corcoran K, Leeder S, Phelps K (2013) Integrative medicine outcomes: what should we measure? Complement Ther Clin Pract 19(1):20–26CrossRefPubMed
33.
Herman PM, Poindexter BL, Witt CM, Eisenberg DM (2012) Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations. BMJ Open 2(5):e001046CrossRefPubMedPubMedCentral
34.
Coulter ID, Herman PM, Nataraj S (2013) Economic analysis of complementary, alternative, and integrative medicine: considerations raised by an expert panel. BMC Complement Altern Med 13(1):1–9CrossRef
35.
Girgs A, Delaney G, Miller A (2015) Utilising eHealth to support survivorship care. Cancer Forum 39(2):86–89
36.
Hibbard JH, Greene J, Overton V (2013) Patients with lower activation associated with higher costs; delivery systems should know their patients scores. Health Aff 32(2):216–222CrossRef
37.
Grant S Case study: patient with history of breast cancer presenting with cancer-related fatigue to an integrative oncology service. Adv Integr Med 2(2):116
38.
Lacey J DH, Lomax A, Marthick M, Mcneil C, Levy D, Kao S (2017) A supportive care intervention for people living with melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability. . In: Multinational Association of Supportive Care in Cancer (MASCC) Conference, 2017, pp 25–25
39.
Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR (2004) Knowledge of and attitudes toward complementary and alternative therapies: a national multicentre study of oncology professionals in Norway. Eur J Cancer 40(4):529–535CrossRefPubMed
40.
Hyodo I, Eguchi K, Nishina T, Endo H, Tanimizu M, Mikami I, Takashima S, Imanishi J (2003) Perceptions and attitudes of clinical oncologists on complementary and alternative medicine. Cancer 97(11):2861–2868CrossRefPubMed
41.
Seely DM, Weeks LC, Young S: A systematic review of integrative oncology programs. Curr Oncol (Toronto, Ont) 2012, 19(6):e436–e461
Metadaten
Titel
Establishing an integrative oncology service in the Australian healthcare setting—the Chris O’Brien Lifehouse Hospital experience
verfasst von
Suzanne J. Grant
Michael Marthick
Judith Lacey
Publikationsdatum
17.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4460-2

Weitere Artikel der Ausgabe 6/2019

Supportive Care in Cancer 6/2019 Zur Ausgabe

Review Article

Assessing patients’ experiences of cancer care across the treatment pathway: a mapping review of recent psychosocial cancer care publications

Original Article

Out-of-pocket-payments and the financial burden of 502 cancer patients of working age in Germany: results from a longitudinal study

Original Article

A review of the Rapid Response Radiotherapy Program in patients with advanced cancer referred for palliative radiotherapy over two decades

Original Article

Presence of gastro-intestinal symptoms in ovarian cancer patients during survivorship: a cross-sectional study from the PROFILES registry

Original Article

One-minute time interval estimation as a novel ultrashort tool for distress screening

Original Article

Patients and caregivers’ unmet information needs in the field of patient education: results from an Italian multicenter exploratory survey

Neu im Fachgebiet Onkologie

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise